Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280865
Status:
COMPLETED
Last Update Posted:
2006-07-31
First Post:
2006-01-20
Brief Title:
GLAD Dose-Finding Efficacy and Safety of AZ 242 Tesaglitazar in Subjects With Type 2 Diabetes
Sponsor:
Organization:
AstraZeneca